$1.21
0.109.55%
At close: -
$1.16
-0.05-3.73%
After Hours: Apr 8, 9:22 AM EDT
Comments
Loading...
Akari Therapeutics Stock Guidance | NASDAQ:AKTX | Benzinga
Akari Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Akari Therapeutics PLC (AKTX) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for Akari Therapeutics (AKTX)?
There have been no specific sales or earnings guidance reported for Akari Therapeutics in recent months.
Browse guidance and forecast on all stocks.
